Laurent Abuaf - Amarin PLC President VP

AMRN Stock  USD 0.53  0.02  3.64%   

President

Laurent Abuaf is President VP of Amarin PLC
Address Iconic Offices, The Greenway, Dublin, Ireland, 112-114
Phone353 0 166 99020
Webhttps://www.amarincorp.com

Amarin PLC Management Efficiency

The company has return on total asset (ROA) of (0.0345) % which means that it has lost $0.0345 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0726) %, meaning that it created substantial loss on money invested by shareholders. Amarin PLC's management efficiency ratios could be used to measure how well Amarin PLC manages its routine affairs as well as how well it operates its assets and liabilities. As of the 25th of November 2024, Return On Tangible Assets is likely to drop to -0.08. In addition to that, Return On Capital Employed is likely to drop to -0.12. At this time, Amarin PLC's Asset Turnover is very stable compared to the past year.
Amarin PLC currently holds 8.74 M in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. Amarin PLC has a current ratio of 2.34, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Amarin PLC's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

PRESIDENT Age

Karen SantiagoBristol Myers Squibb
50
Robin KramerBiogen Inc
58
Joseph EidBristol Myers Squibb
52
Katarina AgeborgAstraZeneca PLC ADR
N/A
James FordGlaxoSmithKline PLC ADR
N/A
Michael SeverinoAbbVie Inc
55
Ruud DobberAstraZeneca PLC ADR
N/A
Peter FasoloJohnson Johnson
61
Franklin ClyburnMerck Company
56
Kathryn WengelJohnson Johnson
55
Jeffrey StewartAbbVie Inc
55
Cristal DowningMerck Company
55
Jasmina BrooksJohnson Johnson
N/A
James SwansonJohnson Johnson
58
Jyoti MehraGilead Sciences
48
Michael SneedJohnson Johnson
60
James BradnerNovartis AG ADR
49
Adam DubowBristol Myers Squibb
53
Samit HirawatBristol Myers Squibb
52
Leon WangAstraZeneca PLC ADR
N/A
Jose BaselgaAstraZeneca PLC ADR
58
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland. Amarin Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 560 people. Amarin PLC (AMRN) is traded on NASDAQ Exchange in USA. It is located in Iconic Offices, The Greenway, Dublin, Ireland, 112-114 and employs 275 people. Amarin PLC is listed under Biotechnology category by Fama And French industry classification.

Management Performance

Amarin PLC Leadership Team

Elected by the shareholders, the Amarin PLC's board of directors comprises two types of representatives: Amarin PLC inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Amarin. The board's role is to monitor Amarin PLC's management team and ensure that shareholders' interests are well served. Amarin PLC's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Amarin PLC's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jason JD, Chief VP
Joseph JD, Exec Counsel
Jordan Zwick, Senior Relations
Alina Kolomeyer, Director Communications
Patrick Holt, CEO President
Nabil Abadir, Chief Affairs
Aaron Berg, Senior Vice President - Marketing and Sales
David Keenan, Executive Europe
Peter Fishman, Global VP
Jonathan Provoost, Executive Officer
Laurent Abuaf, President VP
Donna Pasek, Senior Resources
Karim Mikhail, CEO Pres
Thomas Reilly, Chief Officer
Steven Ketchum, President Officer
Lisa DeFrancesco, Sr Relations

Amarin Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Amarin PLC a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Amarin PLC

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amarin PLC position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amarin PLC will appreciate offsetting losses from the drop in the long position's value.

Moving together with Amarin Stock

  0.61A Agilent TechnologiesPairCorr
  0.71ME 23Andme HoldingPairCorr
  0.77VALN Valneva SE ADRPairCorr
  0.66JNJ Johnson Johnson Fiscal Year End 28th of January 2025 PairCorr

Moving against Amarin Stock

  0.48RNXT RenovoRxPairCorr
  0.41MDGL Madrigal PharmaceuticalsPairCorr
The ability to find closely correlated positions to Amarin PLC could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amarin PLC when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amarin PLC - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amarin PLC to buy it.
The correlation of Amarin PLC is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amarin PLC moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amarin PLC moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amarin PLC can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Amarin PLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amarin PLC's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amarin Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amarin Plc Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amarin PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in Amarin Stock, please use our How to Invest in Amarin PLC guide.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amarin PLC. If investors know Amarin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amarin PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.94)
Earnings Share
(0.10)
Revenue Per Share
0.588
Quarterly Revenue Growth
(0.36)
Return On Assets
(0.03)
The market value of Amarin PLC is measured differently than its book value, which is the value of Amarin that is recorded on the company's balance sheet. Investors also form their own opinion of Amarin PLC's value that differs from its market value or its book value, called intrinsic value, which is Amarin PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amarin PLC's market value can be influenced by many factors that don't directly affect Amarin PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amarin PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amarin PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amarin PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.